News Community Contact

Financial Snapshot

75

Years in Operation

USD

159 mn

Market Capitalisation

37%

Free Float

USD

311 mn

Total Assets

AAA

Long-term Fitch Rating

>5K

Employees

Latest News

Performance Review for the Twelve Months Ended 31 st March 2025

May 22, 2025

Hemas Appoints Dr. Mahesha Ranasoma as Managing Director of Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics to Strengthen Healthcare Partnerships

April 07, 2025

Hemas Hospital Wattala enters Cardiac Care, with Sri Lanka’s Most Advanced Technology in cardiac catheterization

April 04, 2025

VIEW ALL

Group Strategy

Building More from the Core

Accelerate current business efforts to drive higher value in core business

New Within the Core and Adjacencies

Capture new revenue streams to further strengthen the core and adjacencies

New Business and Internationalisation

Explore attractive opportunities in new spaces and international markets

Efficiencies

Efficiency and productivity to further enhance capacity and improve growth

Financial Highlights

Key Performance Indicators

As at 31 March	FY 25	FY 24	FY 23	FY 22	FY 21	FY 20	FY 19	FY 18	FY 17	FY 16
ROE	17.7%	15.3%	13.4%	13.8%	10.3%	4.4%	12.6%	10.4%	14.9%	14.1%
ROCE	25.6%	22.1%	22.9%	17.2%	15.7%	9.6%	16.3%	14.4%	17.5%	16.8%
Earnings per share (Rs.)	2.7	2.05	1.432	1.42	1.1	0.42	1.14	0.9	1.22	0.94
Dividend per share (Rs.)	4	2.35	2.35	4.4	0.4	1.5	4.9	1.9	1.4	1.1
Net Asset Value per share (Rs.)	16.67	14.56	12.88	11.84	10.7	9.36	9.42	8.86	8.7	7.68
Market Capitalization as at March 31 (Rs. Bn)	71.7	48.0	38.8	23.8	49.8	33.5	44.7	71.8	62.3	46.1
Price to Earnings Ratio (Times)	8.9	7.9	9.1	6.5	15.2	27.1	13.3	26.7	17.8	17.1
Share Price as at 31 March (Rs.)	120.00	80.40	65.00	46.2	83.4	56.2	75	124.9	108.7	80.6
Gearing	13.5	22.4%	35.4%	15.2%	17.2%	23.2%	18.2%	19.7%	16.0%	18.5%

2024/2025

2023/2024

2022/2023

2021/2022

2020/2021

2019/2020

2018/2019

2017/2018

2016/2017

2015/2016

2014/2015

2013/2014

2012/2013

2011/2012

2010/2011

2009/2010

2008/2009

2007/2008

2006/2007

2005/2006

2004/2005

2003/2004

2024/2025

2024/2025

2024/2025

2024/2025

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2024/2025

2024/2025

Q1 Presentations

Q2 Presentations

Q3 Presentations

Q1 Earnings Call

Q2 Earnings Call

Q3 Earnings Call

2023/2024

2023/2024

2023/2024

2023/2024

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2023/2024

2023/2024

Q1 Presentations

Q2 Presentations

Q3 Presentations

Q4 Presentations

Q1 Earnings Call

Q2 Earnings Call

Q3 Earnings Call

Q4 Earnings Call

2022/2023

2022/2023

2022/2023

2022/2023

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2022/2023

2022/2023

Q1 Presentations

Q2 Presentations

Q3 Presentations

Q4 Presentations

Q2 Earnings Call

Q3 Earnings Call

Q4 Earnings Call

2021/2022

2021/2022

2021/2022

2021/2022

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2021/2022

2021/2022

Q1 Presentations

Q2 Presentations

Q3 Presentations

Q4 Presentations

2020/2021

2020/2021

2020/2021

2020/2021

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2020/2021

2020/2021

Q1 Presentations

Q3 Presentations

Q4 Presentations

2019/2020

2019/2020

2019/2020

2019/2020

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2019/2020

2019/2020

Q1 Presentations

Q2 Presentations

Q4 Presentations

2018/2019

2018/2019

2018/2019

2018/2019

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2018/2019

2018/2019

Q1 Presentations

Q2 Presentations

Q3 Presentations

Q4 Presentations

2017/2018

2017/2018

2017/2018

2017/2018

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2017/2018

2017/2018

Q1 Presentations

Q2 Presentations

Q3 Presentations

Q4 Presentations

2016/2017

2016/2017

2016/2017

2016/2017

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2016/2017

2016/2017

Q1 Presentations

Q2 Presentations

Q3 Presentations

Q4 Presentations

Annual Report
Quarterly Reports

2015/2016

2015/2016

2015/2016

2015/2016

Q1 Report

Q2 Report

Q3 Report

Q4 Report

Annual Report
Quarterly Reports

2014/2015

2014/2015

2014/2015

2014/2015

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2013/2014

2013/2014

2013/2014

2013/2014

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2013/2014

2013/2014

Q1 Presentations

Q3 Presentations

2012/2013

2012/2013

2012/2013

2012/2013

Q1 Report

Q2 Report

Q3 Report

Q4 Report

2012/2013

2012/2013

Q1 Presentations

Q3 Presentations

Annual Report
Quarterly Reports

2011/2012

2011/2012

2011/2012

2011/2012

Q1 Report

Q2 Report

Q3 Report

Q4 Report

Annual Report
Quarterly Reports

2010/2011

2010/2011

2010/2011

2010/2011

Q1 Report

Q2 Report

Q3 Report

Q4 Report

Annual Report
Quarterly Reports

2009/2010

2009/2010

2009/2010

2009/2010

Q1 Report

Q2 Report

Q3 Report

Q4 Report

Annual Report

2008/2009

2008/2009

Annual Report

2007/2008

2007/2008

Annual Report

2006/2007

2006/2007

Annual Report

2005/2006

2005/2006

Annual Report

2004/2005

2004/2005

Annual Report

2003/2004

2003/2004

Events

Upcoming Events
Past Events

No events!

Filter by Year

Virtual EGM

30 June 2021

No 75, Braybrooke Place, Colombo 2

30 June 2021

3:30 PM - (GMT+5.30)

Hemas Holdings PLC – 71st Annual General Meeting

11 August 2020

Registered Office, Hemas House No 75, Braybrooke Place, Colombo 2

11 August 2020

3.30 PM - (GMT+5.30)

Q3 2020 Earnings Call

14 February 2020

14 February 2020

Q2 2020 Earnings Call

19 November 2019

19 November 2019

Q1 2020 Earnings Call

09 August 2019

09 August 2019

Year-end analyst meeting

13 June 2019

13 June 2019

2.00 PM – 3.00 PM (GMT+5.30)

CT CLSA Colombo forum

10 June 2019

Visit Here

10 June 2019

CEO’s Review Q4 2018/2019

24 May 2019

24 May 2019

Year-end earnings call

30 March 2019

30 March 2019

2.00PM – 3.00PM (GMT+5.30)

Release of Annual Report 2018/2019

29 March 2019

29 March 2019

Invest Sri Lanka forum, Singapore on May 21, 2019

14 March 2019

Visit Here

14 March 2019

CEO’s Review Q3 2018/2019 : Hemas reports an operating profit growth of 46% as Atlas acquisition delivers on its peak season

07 February 2019

07 February 2019

CEO’s Review Q2 2018/2019 : Hemas Holdings PLC’s operating profit up by 22.5%

01 February 2019

01 February 2019

CEO’s Review Q1 2018/2019 : Hemas Group recorded a revenue of Rs.13.5Bn, a year-on year growth of 21.3%, led by higher contributions in our consumer and healthcare sectors

17 January 2019

17 January 2019

CEO’s Review Q4 – 2017/2018

28 May 2018

28 May 2018

CEO’s Review Q3 – 2017/2018 : Hemas Holdings PLC reported a consolidated revenue of Rs.35.6Bn for the first nine months, up by 11.4%

12 February 2018

12 February 2018

Hemas integrated logistics rebranded as spectra integrated logistics

01 February 2018

01 February 2018

Hemas Consolidated FMCG position by acquiring Atlas – Sri Lanka’s most loved brand of 2017

19 January 2018

19 January 2018

CEO’s Review Q2 2017/2018: Hemas Achieves Revenue Growth of 11.6%

14 November 2017

14 November 2017

‘Hemas cash back’ VAT Reclaim Service helps travellers transform trash into cash

22 May 2017

22 May 2017

Hemas and GAC to Build a World – class Integrated Logistics Facility in Muthurajawela Industrial Zone

27 January 2017

27 January 2017

Hemas Aviation appointed as GSA for EVA Air

19 January 2017

19 January 2017

Hemas continues to grow its earnings reporting 47% growth for the first half of the year

07 November 2016

07 November 2016

Contact Investor Relations

Hemas House, No 75, Braybrooke Place, Colombo 02

+94 76 6934308

ir@hemas.com

enable JavaScriptOpenWidget

Get instant investor insights!

Whether it's deciphering annual reports, tracking market trends, or finding any other investor information, Chat with our Hemas AI Bot to get the insights you need in seconds!